Robuta

https://pubmed.ncbi.nlm.nih.gov/32045136/
To our knowledge, this is the first regional population-based multistep model that is aimed to identify individuals with BRCA1/2 mutations and to offer an...
hereditary breast cancerscreening toolregionalpopulationbased
https://pubmed.ncbi.nlm.nih.gov/35079980/
Breast cancer is the most common cancer diagnosed in women worldwide, with approximately 5-10% of cases attributed to high penetrance hereditary breast cancer...
hereditary breast cancergenetic servicesoverviewdelivery
https://pubmed.ncbi.nlm.nih.gov/39712953/
iKNOW tends to positively influence the understanding of familial cancer risk. At the same time, it does not negatively influence any of the secondary...
iknowsupportingcounselingwomenhereditary
https://www.southampton.ac.uk/medicine/research/posh.page
prospective studyoutcomessporadicversushereditary
https://pubmed.ncbi.nlm.nih.gov/17901820/?dopt=Abstract
Approximately 5% to 10% of breast and ovarian cancers are related to an inherited gene mutation. Of these cases, 84% of hereditary breast cancer and more than...
ovarian cancermedical managementhereditarybreastclinical
https://www.ncbi.nlm.nih.gov/clinvar/RCV000048820.3/
ClinVar archives and aggregates information about relationships among variation and human health.
nmchereditary
https://www.cdc.gov/breast-ovarian-cancer-hereditary/genetic-counseling/index.html
Genetic counseling can help you make informed decisions about genetic testing.
genetic counselingovarian cancerhereditarybreast
https://pubmed.ncbi.nlm.nih.gov/9150172/
BRCA2 mutations in hereditary breast and ovarian cancer in France
ovarian cancermutationshereditarybreastfrance
https://www.questdiagnostics.com/healthcare-professionals/clinical-education-center/faq/faq238
What is the clinical application of the Hereditary Breast Cancer Panel? This test is used to help identify individuals with a hereditary predisposition to...
hereditary breast cancerquest diagnosticspanel